Premier Health of America Inc (PHA) AI Stock Analysis

• Market Cap: C$1.11M
• Dividend Yield: N/A
• Average Volume (3M): 33.75K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.95
• Revenue Growth: -22.61%
• EPS Growth: 7.72%
• Country: CA
• Employees: 589
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.06
• Shares Outstanding: 55,514,153
• 10 Day Avg. Volume: 13,466
• 30 Day Avg. Volume: 33,746
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.15
• Price to Sales (P/S): 0.02
• P/FCF Ratio: 0.14
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: C$0.02 ▼(-25.00% Downside)
• Action: Reiterated Date: 02/03/26
• Date: Action: Reiterated 02/03/26

The score is primarily held down by weak financial performance—sharp margin compression, widening losses, and a high-risk balance sheet with negative equity—partially offset by improved operating and free cash flow. Technicals add a mild drag due to negative MACD and price below longer-term moving averages, while valuation is neutral-to-weak given the loss-making (negative P/E) profile and no dividend yield support.

Positive Factors

Cash Generation

Improved operating and free cash flow in 2025 shows the company can generate liquidity from operations despite accounting losses. Sustainable cash conversion affords tactical flexibility to fund operations, invest selectively, or shore up working capital, reducing near-term refinancing urgency over the next several months.

Debt Reduction

A modest decline in total debt in 2025 slightly eases leverage and interest burden relative to 2024. While not decisive given negative equity, incremental deleveraging can improve creditor perception, marginally expand financing optionality and reduce immediate solvency pressure over a medium-term horizon.

Proven Scaling Ability

Historical multi-year revenue growth through 2024 indicates the business model and operations can scale when market conditions are favorable. This operational track record implies repeatable sales, delivery and client relationships that could support a recovery in top-line growth if margins or demand normalize.

Negative Factors

Revenue & Margin Deterioration

An ~11% revenue decline and gross margin collapse to ~8% in 2025 reflect structural pressure on pricing, utilization or cost control. Continued top-line shrinkage and margin erosion reduce operating leverage, impair long-term profitability and limit the company's ability to self-fund investment or capital needs.

Negative Shareholders' Equity

Shareholders' equity turning negative in 2025 signals capital erosion and materially reduced financial flexibility. Negative equity complicates access to debt or equity markets, raises covenant and default risk, and increases the likelihood of dilutive financings or restructuring over the medium term.

Weak Coverage Despite FCF

Despite headline improvements in free cash flow, operating cash flow coverage remained well below 1, highlighting a cash/earnings disconnect. Insufficient coverage means recurring obligations and interest are not comfortably met by core cash flows, elevating refinancing risk and constraining sustainable reinvestment.

Premier Health of America Inc Business Overview & Revenue Model

Company Description

Premier Health of America Inc., a specialized healthcare services company, provides staffing and outsourced service solutions for healthcare needs in Canada. It also offers health consulting, nursing, and health-care services in remote communities, as well as medical transport services; and Code Bleu, an agency to employ nurses, caregivers, dental staff, and other health-related personnel. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company was founded in 2003 and is headquartered in Blainville, Canada.

How the Company Makes Money

PHA generates revenue through multiple streams, primarily from the sales of medical supplies and equipment to healthcare providers and patients. The company also earns income from its home healthcare services, which include nursing, rehabilitation, and telehealth consultations. Additionally, PHA has established partnerships with healthcare facilities and insurance companies that facilitate service contracts and reimbursement agreements, contributing significantly to its earnings. The increasing demand for home healthcare solutions and the expansion of telehealth services in response to changing healthcare dynamics further bolster PHA's revenue model.

Premier Health of America Inc Financial Statement Overview

Summary

Overall financials appear stressed: profitability deteriorated sharply in 2025 with revenue down ~11% YoY, gross margin collapsing to ~8%, and losses widening to about -15% of revenue. The balance sheet is a major risk with stockholders’ equity turning negative (despite modest debt reduction). The main offset is improved operating cash flow and stronger free cash flow in 2025, though coverage of obligations remains low and the cash/earnings disconnect raises sustainability concerns.

Income Statement

Profitability has deteriorated meaningfully. Revenue fell sharply in 2025 (down ~11% YoY) after strong multi-year growth through 2024, and margins compressed heavily: gross margin dropped to ~8% (from ~18% in 2024 and ~25% in 2022–2023). The company moved from near break-even operating performance in 2024 to a sizable operating loss in 2025, with net losses widening to roughly -15% of revenue. Strength: the business previously demonstrated the ability to scale revenue (2020–2024), but the current earnings profile is weak and volatile.

Balance Sheet

Balance sheet risk is elevated. Stockholders’ equity turned negative in 2025, which materially reduces financial flexibility and increases downside risk. Debt remains high relative to the company’s capital base (debt-to-equity becomes distorted/negative due to negative equity), following already-heavy leverage in 2024. Total assets also contracted notably from 2024 to 2025, consistent with a shrinking balance sheet. Strength: total debt did decline modestly in 2025 versus 2024, but the negative equity position dominates the credit profile.

Cash Flow

Cash generation is a relative bright spot despite weak earnings. Operating cash flow improved materially in 2025 and free cash flow was strong (and up sharply versus 2024), indicating improved cash conversion and/or working-capital benefits. However, cash flow coverage of obligations remains low (operating cash flow coverage ratio stayed well below 1 across years), and the contrast between strong cash flow and large net losses in 2025 raises sustainability questions. Strength: recent free cash flow momentum is positive; weakness: coverage and earnings quality remain concerns.

Breakdown	Dec 2024	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Income Statement
Total Revenue	101.97M	158.19M	90.39M	80.51M	66.63M
Gross Profit	8.40M	27.89M	23.34M	20.08M	16.25M
EBITDA	-3.67M	384.00K	5.87M	5.61M	5.90M
Net Income	-15.44M	-12.49M	-1.70M	-111.51K	1.50M
Balance Sheet
Total Assets	47.22M	73.72M	56.71M	57.09M	39.13M
Cash, Cash Equivalents and Short-Term Investments	1.40M	1.50M	1.15M	5.12M	2.68M
Total Debt	45.34M	49.85M	27.27M	22.84M	12.30M
Total Liabilities	58.49M	69.64M	40.27M	38.62M	21.81M
Stockholders Equity	-11.27M	4.08M	16.44M	18.47M	17.32M
Cash Flow
Free Cash Flow	12.33M	3.02M	-3.20M	3.38M	24.13K
Operating Cash Flow	12.45M	5.93M	-1.27M	4.04M	1.97M
Investing Cash Flow	-2.53M	-26.43M	-3.33M	-12.67M	-16.08M
Financing Cash Flow	-10.02M	20.85M	625.00K	11.07M	15.56M

Premier Health of America Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:PHA, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 47.97 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:PHA.

Premier Health of America Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DR	76 Outperform	C$289.42M	2.28	39.85%	2.35%	-40.05%	558.77%
CRRX	59 Neutral	C$239.65M	3,820.00	0.11%	1.03%	0.19%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
PHA	44 Neutral	C$1.11M	-0.05	-1473.72%	―	-22.61%	7.72%
NUMI	41 Neutral	C$13.86M	―	―	―	―	―

Premier Health of America Inc Corporate Events

Premier Health of America Widens Loss as It Exits Per Diem Segment and Refocuses on Travel Nurses

Premier Health of America reported a sharp year-over-year decline in fiscal 2025 results, with annual revenues falling to $101.97 million from $158.19 million and adjusted EBITDA dropping to $1.67 million from $6.56 million, alongside a widened net loss of $15.44 million. Fourth-quarter performance reflected these pressures, as revenue slid to $20.79 million and net loss deepened to $6.5 million, driven primarily by reduced volumes in Quebec and British Columbia and the continued impact of Quebec’s Bill 10, which capped rates for independent labor and effectively reduced the contribution of the Per Diem segment to under 4% of annual revenue before its abandonment in early 2026. In response, the company is executing a cost-reduction and reorganization plan, notably cutting staff in Quebec and at the corporate level, trimming salary expenses by $0.7 million in the quarter despite one-time management benefits, and adjusting its British Columbia cost structure, while strategically pivoting its focus toward travel nurse services and evaluating expansion opportunities in home care and Ontario tenders to restore growth and improve operational efficiency.